New insight into the intravenous immunoglobulin treatment in Multisystem Inflammatory Syndrome in children and adults
Abstract Within 6 months of the coronavirus pandemic, a new disease entity associated with a multisystem hyperinflammation syndrome as a result of a previous infection with the SARS-CoV-2 virus is increasingly being identified in children termed Multisystem Inflammatory Syndrome in Children (MIS-C)...
Saved in:
Main Authors: | Chih-Jen Chen (Author), Hsu-Yen Kao (Author), Ching-Hua Huang (Author), Chia-Jung Li (Author), Cheng-Hsien Hung (Author), Su-Boon Yong (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Successful use of tocilizumab in the treatment of multisystem inflammatory disease of childhood refractory to intravenous immunoglobulin and glucocorticoids
by: Jitendra S Oswal, et al.
Published: (2021) -
Multisystem inflammatory syndrome in children treated with intravenous immunoglobulin monotherapy: a single-center retrospective study
by: Murat Kangin, et al.
Published: (2024) -
A retrospective comparative analysis of factors affecting the decision and outcome of initial intravenous immunoglobulin alone or intravenous immunoglobulin plus methylprednisolone use in children with the multisystem inflammatory syndrome
by: İlker Devrim, et al.
Published: (2022) -
Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial
by: Ho-Chang Kuo, et al.
Published: (2018) -
Intravenous Immunoglobulins: Mode of Action and Indications in Autoimmune and Inflammatory Dermatoses
by: Lyubomir A. Dourmishev, et al.
Published: (2016)